Congenital CMV and Hearing Loss in Children up to 4 Years of Age: Treating With Valganciclovir Therapy

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by University of Alabama at Birmingham
Sponsor:
Information provided by (Responsible Party):
David Kimberlin, MD, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT01649869
First received: July 20, 2012
Last updated: March 6, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)